NCT02593123
- Conditions
- Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Blood Protein Disorders, +45 more
- Locations
-
- Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States
Clinical trial condition
Acute Myelogenous Leukemia
Explore clinical trials studying Acute Myelogenous Leukemia. Study availability and eligibility vary by location and protocol.
154 public trials
8 recruiting studies
Acute Myelogenous Leukemia trial results
NCT01364363
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Anemia, +47 more
- Locations
-
- Scripps Green Hospital La Jolla, California, United States
Completed
Nonmyeloablative Allogeneic Transplant
NCT01272817
- Conditions
- Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Adenocarcinoma, +91 more
- Locations
-
- Scripps Green Hospital La Jolla, California, United States
NCT01586455
- Conditions
- Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Adrenal Gland Diseases, +84 more
- Locations
-
- Children's Hospital Colorado Denver, Colorado, United States
- New York Medical College Valhalla, New York, United States
- University of Utah Salt Lake City, Utah, United States
NCT01842672
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Burkitt Lymphoma, +26 more
- Locations
-
- New York Medical College Valhalla, New York, United States
- Levine Children's Hospital Charlotte, North Carolina, United States
NCT02287233
- Conditions
- AML, Acute Myelogenous Leukemia, Hematologic Diseases, +6 more
- Locations
-
- Univ Kansas Med Ctr /ID# 131175 Kansas City, Kansas, United States
- Weill Cornell Medical College /ID# 131170 New York, United States
- University of Pittsburgh MC /ID# 131168 Pittsburgh, Pennsylvania, United States
- Vanderbilt University Medical Center /ID# 131177 Nashville, Tennessee, United States
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Blood Protein Disorders, +23 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
Completed
Study of Decitabine in Combination With Sequential Rapamycin or Ribavirin in High Risk AML Patients
NCT02109744
- Conditions
- Acute Myelogenous Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- University of Rochester Rochester, New York, United States
NCT02566395
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +27 more
- Locations
-
- Cohen Children's Medical Center New Hyde Park, New York, United States
NCT04014764
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Blood Protein Disorders, +31 more
- Locations
-
- CBCC Global Research Bakersfield, California, United States
- Pacific Central Coast Health Centers -- SLO Oncology and Hematology Health Center San Luis Obispo, California, United States
- Colorado West Healthcare System, dba Grand Valley Oncology Grand Junction, Colorado, United States
- Ocala Oncology Center Ocala, Florida, United States